<--- Back to Details
First PageDocument Content
Muscular dystrophy / Duchenne muscular dystrophy / Exon skipping / Dystrophin / Mdx mouse / Adeno-associated virus / Morpholino / Viral vector / Draft:SRP-4044 / Draft:BMN 044
Date: 2014-04-17 10:21:48
Muscular dystrophy
Duchenne muscular dystrophy
Exon skipping
Dystrophin
Mdx mouse
Adeno-associated virus
Morpholino
Viral vector
Draft:SRP-4044
Draft:BMN 044

Action Duchenne Research Strategy Version)- Post national meeting 1

Add to Reading List

Source URL: www.actionduchenne.org

Download Document from Source Website

File Size: 1,05 MB

Share Document on Facebook

Similar Documents

Muscular dystrophy / RTT / Biology / Genetics / Clinical medicine / Exon skipping / Duchenne muscular dystrophy / Zinc finger nuclease / Morpholino / Dystrophin / DMD / Draft:BMN 044

Research Review No. 88. Recent exciting new Developments; A general oveview. The Studies:

DocID: 1qUta - View Document

Muscular dystrophy / Drisapersen / Duchenne muscular dystrophy / Exon skipping / Draft:BMN 044 / Dystrophin / DMD / Draft:SRP-4044

Research Review No. 86. Recent exciting new Developments. A general oveview. Introduction:

DocID: 1phvg - View Document

Muscular dystrophy / Biotechnology / Duchenne muscular dystrophy / Sarepta Therapeutics / PTC Therapeutics / Exon skipping / Clinical trial / BioMarin Pharmaceutical / Draft:BMN 044 / Draft:SRP-4044

ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and Dubl

DocID: 1oCyv - View Document

Muscular dystrophy / Duchenne muscular dystrophy / Exon skipping / Dystrophin / Mdx mouse / Adeno-associated virus / Morpholino / Viral vector / Draft:SRP-4044 / Draft:BMN 044

Action Duchenne Research Strategy Version)- Post national meeting 1

DocID: 1os3c - View Document

For a richer research landscape in Leiden The use of exon skipping in ALK4 and ALK5 for treatment of muscular dystrophies and other disorders Market sectors: Fibrosis, Muscular Dystrophy, Spinal Muscular Atrophies,

DocID: 1eiSL - View Document